Effect of a multidisciplinary program of weight reduction on endothelial functions in obese women.
Obesity is associated with an increased risk of developing atherosclerosis and atherosclerotic lesions are essentially an inflammatory response. The aim of this study was to evaluate the effect of a medically supervised, multidisciplinary weight loss program on endothelial functions and circulating levels of proinflammatory cytokines in obese women. Twenty healthy pre-menopausal obese women and 20 age-matched normal weight women were studied. Endothelial functions were assessed by evaluating the response of blood pressure and platelet aggregation to an intravenous bolus of L-arginine (3 g), the natural precursor of nitric oxide. In obese women, the vascular and rheological responses to L-arginine were significantly lower (p < 0.05) at baseline, as compared with non-obese women, indicating endothelial dysfunction; on the contrary, basal concentrations of tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) were significantly higher (p < 0.01). After one year of a multidisciplinary program of weight reduction consisting of diet, exercise and liposuction surgery, all obese women lost at least 10% of their original weight (10.5 +/- 1.7 kg, range 7.9-13.9 kg). Compared with baseline, sustained weight loss was associated with reduction of cytokine (p < 0.01) concentrations and with improvement of vascular responses to L-arginine. In conclusion, a multidisciplinary approach aimed at inducing a sustained reduction of body weight in obese women is feasible and is associated with improvement of endothelial functions and reduction of circulating proinflammatory cytokine concentrations.
Nicoletti
G
G
Chair of Plastic and Reconstructive Surgery, Second University of Naples, Naples, Italy.
Giugliano
G
G
Pontillo
A
A
Cioffi
M
M
D'Andrea
F
F
Giugliano
D
D
Esposito
K
K
D000328:Adult; D016022:Case-Control Studies; D003376:Counseling; D004730:Endothelium, Vascular / Q000503:physiopathology*; D015444:Exercise; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000097:blood; D015187:Lipectomy; D009747:Nutritional Physiological Phenomena; D009765:Obesity / Q000178:diet therapy / Q000503:physiopathology* / Q000628:therapy*; D010348:Patient Care Team; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D015431:Weight Loss
D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha